Stay updated with breaking news from Sip Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the institution decision for Mylan Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc., IPR2022-01225, Paper 21 (P.T.A.B. Jan. 11, 2023), the Patent Trials & Appeals Board ("the Board")...
The European Commission is seeking innovative blockchain solutions for the European Blockchain Services Infrastructure; 7 contractors completed the first solution design phase and 5 were awarded procurement contracts for the second.
In Qualcomm Inc. v. Intel Corp., the Federal Circuit held that Qualcomm was not afforded notice of, or an adequate opportunity to respond to, the Patent Trial and Appeal Board's (PTAB's)...
To embed, copy and paste the code into your website or blog: C. R. Bard Inc. and Bard Peripheral Vascular, Inc. (collectively, Bard), and AngioDynamics, Inc., manufactured vascular access ports that were inserted under a patient’s skin to enable medical providers to insert fluid into the patient’s veins without having to initiate a new intravenous line. The Food and Drug Administration (FDA) warned medical providers not to use vascular access ports for power injection unless the ports were labeled for such use. 1 Bard sold vascular ports that could be used for power injection, even though...